Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. vascular endothelial growth factor c vegf c and vegf d is not equivalent to vegf
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Brands

  • medchemexpress
  • all chemistry inc.
  • clearside
  • ikarovec
  • lonza
View all brands

Vascular Endothelial Growth Factor C Vegf C And Vegf D Is Not Equivalent To Vegf Equipment & Supplies

155 equipment items found

ALL Chemistry Inc. - Model SVEG10806 - Oglufanide

ALL Chemistry Inc. - Model SVEG10806 - Oglufanide

Manufactured by:ALL Chemistry Inc.   based inMarlton, NEW JERSEY (USA)
Oglufanide is a naturally occurring thymic immunomodulator,and inhibits vascular endothelial growth factor ...
CONTACT SUPPLIER

EirGenix - Model EG12021 - Bevacizumab Biosimilar

EirGenix - Model EG12021 - Bevacizumab Biosimilar

Manufactured by:EirGenix, Inc   based inNew Taipei City, TAIWAN
Product: EG12021 Bevacizumab Biosimilar. Indication: Cancer. Target: VEGF. Status: ...
CONTACT SUPPLIER

ALL Chemistry Inc. - Model SVEG10793 - SU5208

ALL Chemistry Inc. - Model SVEG10793 - SU5208

Manufactured by:ALL Chemistry Inc.   based inMarlton, NEW JERSEY (USA)
SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 ...
CONTACT SUPPLIER

Trichosera - Novel Scalp Hair Serum

Trichosera - Novel Scalp Hair Serum

Manufactured by:Stempeutics Research Pvt. Ltd.    based inBangalore, INDIA
A hair serum prepared from the bio-active medium of stem cells that promotes scalp hair growth and reduces hair ...
CONTACT SUPPLIER

Hamster - Model 1 (9-plex) - H101-K - Cytokine Panel

Hamster - Model 1 (9-plex) - H101-K - Cytokine Panel

Manufactured by:Ampersand Biosciences   based inLake Clear, NEW YORK (USA)
Hamster Cytokine Panel 1 detects 9 cytokines and growth factors (IL-2, IL-4, IL-6, IFNγ, MCP-1, MIP-1α, TNFα & VEGF) in a pre-mixed multiplex assay, developed and validated for the Luminex ...
CONTACT SUPPLIER

Perioptisera - Novel Under Eye Serum

Perioptisera - Novel Under Eye Serum

Manufactured by:Stempeutics Research Pvt. Ltd.    based inBangalore, INDIA
An under-eye dark circle reduction serum prepared from the bio-active medium of stem cells that reduces under eye dark circles, rehydrates and soothes the ...
CONTACT SUPPLIER

Cutisera - Novel Anti-Ageing Serum

Cutisera - Novel Anti-Ageing Serum

Manufactured by:Stempeutics Research Pvt. Ltd.    based inBangalore, INDIA
A novel anti-ageing serum with stem cell derived bioactive factors which promote firm, well moisturized and brighter skin with reduced blemishes and fine ...
CONTACT SUPPLIER

Ikarovec - Age-Related Macular Degeneration (AMD) Biotechnology

Ikarovec - Age-Related Macular Degeneration (AMD) Biotechnology

Manufactured by:Ikarovec   based inNorwich, UNITED KINGDOM
Age-related macular degeneration (AMD) is a painless eye condition that leads to the gradual loss of central vision and is the most common cause of sight loss in the developed world and the third most common globally. Around 600,000 people in the UK currently have sight loss caused by AMD and around 70,000 new cases are diagnosed every year. Macular degeneration develops when the macula (the part ...
CONTACT SUPPLIER

Henlius - Model HLX04-O - Bevacizumab Injection

Henlius - Model HLX04-O - Bevacizumab Injection

Manufactured by:Shanghai Henlius Biotech, Inc   based inShanghai, CHINA
HLX04-O, recombinant anti-VEGF humanised monoclonal antibody injection. It is indicated for wet age-related macular degeneration (wAMD). HLX04-O was granted Phase 3 clinical study approvals in Australia, the United States, Singapore and the EU countries such as Latvia, Hungary and Spanish. In April 2022, the first patient in Australia and Latvia was dosed in the global multicentre phase 3 ...
CONTACT SUPPLIER

Olinvacimab - Model TTAC-0001 - Anti-Angiogenic Antibody

Olinvacimab - Model TTAC-0001 - Anti-Angiogenic Antibody

Manufactured by:PharmAbcine Inc.   based inYuseong-gu, SOUTH KOREA
Olinvacimab is an anti-angiogenic antibody that neutralizes the VEGF/VEGFR2 pathway, thus inhibiting tumor growth and ...
CONTACT SUPPLIER

PharmAbcine - Model PMC-403 - Monoclonal Antibody

PharmAbcine - Model PMC-403 - Monoclonal Antibody

Manufactured by:PharmAbcine Inc.   based inYuseong-gu, SOUTH KOREA
PMC-403 is a monoclonal antibody that targets the human TIE2 that regulate the angiogenesis and vessel maturation in endothelial cells. It binds to TIE2 expressing endothelial cells and normalize VEGF-induced pathological leaky blood vessels in eyes and TME (tumor ...
CONTACT SUPPLIER

Stem Pharm - Synthetic Substrates

Stem Pharm - Synthetic Substrates

Manufactured by:Stem Pharm, Inc   based inMadison, WISCONSIN (USA)
Stem Pharm’s technologies are based on functionalized multi-arm polyethylene glycol monomers that incorporate bioactive peptides to modulate adhesion and biomechanical properties. Our optimized substrates generate appropriate cellular environments that improve outcomes for cell expansion, differentiation, and in vitro cell-based ...
CONTACT SUPPLIER

Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

by:Onegene Biotechnology   based inSuwon, SOUTH KOREA
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
CONTACT SUPPLIER

Invivo - Gel

Invivo - Gel

Manufactured by:ROKIT Healthcare   based inGeumcheon-gu, SOUTH KOREA
First, INVIVO GEL provides a degree of freedom to tune the elastic modulus (or stiffness) according to user’s specific needs by changing concentration of INVIVO GEL (GELMA) and Gel-linker (A), a photo initiator. Also, by changing UV light (365㎚) exposure time, degree of cross-linking can be adjusted. Second, special INVIVO GEL formulation mimics extracellular ...
CONTACT SUPPLIER

Lonza - Model EGM -2 MV - Microvascular Endothelial Cell Growth Medium-2 BulletKit

Lonza - Model EGM -2 MV - Microvascular Endothelial Cell Growth Medium-2 BulletKit

Manufactured by:Lonza Group Ltd    based inBasel, SWITZERLAND
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial ...
CONTACT SUPPLIER

Lonza - Model EGM-2 - Endothelial Cell Growth Medium-2 BulletKit

Lonza - Model EGM-2 - Endothelial Cell Growth Medium-2 BulletKit

Manufactured by:Lonza Group Ltd    based inBasel, SWITZERLAND
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells. Available for immediate ...
CONTACT SUPPLIER

Ikarovec - Diabetic Macular Edema (DME) Biotechnology

Ikarovec - Diabetic Macular Edema (DME) Biotechnology

Manufactured by:Ikarovec   based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 diabetes, the chance of developing retinopathy after 10 years is between 67% and 80%. DME is caused by blood vessels in ...
CONTACT SUPPLIER

Kalaris - TH103 for Retinal Disease Treatment

Kalaris - TH103 for Retinal Disease Treatment

Manufactured by:Kalaris   based inWaltham, MASSACHUSETTS (USA)
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative conditions. Their lead product, TH103, is a fully humanized, recombinant fusion protein designed for intravitreal delivery as an anti-VEGF agent. TH103 functions as a soluble decoy receptor, ...
CONTACT SUPPLIER

Avastin (Bevacizumab)

Avastin (Bevacizumab)

by:F. Hoffmann-La Roche Ltd.    based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
CONTACT SUPPLIER

GENLISA - Human VEGF Elisa

GENLISA - Human VEGF Elisa

Manufactured by:Krishgen Biosystems    based inMumbai, INDIA
ELISA Features include:- Ready to use protocol, Standardisation and High Reproducibility, Lot to Lot Consistency, Accuracy and Precision. Validated against seven points for a Gold Ring Standard Quality ELISA - the benchmark sign for Krishgen quality, Long shelf-life, Expert technical support. The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT